The IPO Buzz: Aktis Oncology (AKTS Proposed) Upsizes IPO by 50 Percent to Raise $300 Million
Boston-based Aktis Oncology (AKTS Proposed) upsized its IPO by 50 percent – by increasing the number of shares to 17.65 million – UP from 11.78 million – and kept the price range at $16.00 to $18.00 – to raise $300.05 million, if priced at the $17.00 mid-point of its range, according to an S-1/A filing early […]
January 7, 2026 Read More